Document Classification

Section Type: RESULTS

Text: At 4 years, the rates of progression of diabetic retinopathy were 7. 3 % with intensive glycemia treatment, versus 10. 4 % with standard therapy (adjusted odds ratio, 0. 67 ; 95 % confidence interval [CI], 0. 51 to 0. 87 ; P = 0. 003) ; 6. 5 % with fenofibrate for intensive dyslipidemia therapy, versus 10. 2 % with placebo (adjusted odds ratio, 0. 60 ; 95 % CI, 0. 42 to 0. 87 ; P = 0. 006) ; and 10. 4 % with intensive blood-pressure therapy, versus 8. 8 % with standard therapy (adjusted odds ratio, 1. 23 ; 95 % CI, 0. 84 to 1. 79 ; P = 0. 29).